The global in situ hybridization market size is expected to reach USD 2.55 billion by 2030, registering a CAGR of 7.2% during the forecast period. Situ Hybridization (ISH) is extensively utilized for research and clinical applications of diagnostics. ISH is a popular approach among researchers as it aids in determining the relationship between the distribution of specific nucleic acids and the target gene protein products. Hence, expanding the scope of ISH in applications is accelerating and leading to further research. ![Global In Situ Hybridization Market]( "Global In Situ Hybridization Market")
The increasing awareness about ISH techniques and their usage encourages researchers to employ the techniques for various applications. For instance, the CEO of MultiplexDX stated in an interview with Elsevier that FISH technology can contribute breakthrough information for early drug development and personalized treatment. A growing number of people in developed countries are opting for personalized treatment owing to an increase in awareness, thus boosting market demand.
Furthermore, reimbursement schemes being made available in developed economies have led to an increase in demand for this diagnosis. The demand continues to increase as the majority of the public can now afford it due to the recent expansion through insurance coverage. For instance, Medicare is the largest market player in the U.S., which provides care for those aged 65 years and above, irrespective of their income and medical history.
Owing to the COVID-19 pandemic, the demand side showcased a positive impact on the ISH market as various researchers employed the technique on COVID-19-infected cells. Research published in July 2020, considered 8 autopsy lungs, 10 kidney biopsies, and 1 placenta from COVID-19-infected patients with ISH assay and RNA probes.
COVID-19 positive results showed in all 8 lungs and the placenta by ISH, but not in the kidney samples. The assay showcases a sensitive and specific technique for detecting the virus from tissue samples. Similarly, Advanced Cell Diagnostics, Inc., introduced RNAscope technology to support COVID-19 research.
The growing strategic initiatives by the companies are anticipated to boost the ISH market growth. Key players are introducing novel products in the market to strengthen their portfolios. For instance, in March 2021, F. Hoffmann-La Roche launched DISCOVERY Green HRP chromogen detection kit to expand the multiplexing capability of in situ hybridization and immunohistochemistry.
On the other hand, molecular diagnostics renders accurate & effective results and has indispensable applications in the field of diagnosis. However, the high manufacturing cost of FISH assays and the high amount of capital required for specialized assembly plants & maintenance of instruments used in FISH imaging are likely to limit revenue generation.
The increasing awareness about ISH techniques and their usage encourages researchers to employ the techniques for various applications. For instance, the CEO of MultiplexDX stated in an interview with Elsevier that FISH technology can contribute breakthrough information for early drug development and personalized treatment. A growing number of people in developed countries are opting for personalized treatment owing to an increase in awareness, thus boosting market demand.
Furthermore, reimbursement schemes being made available in developed economies have led to an increase in demand for this diagnosis. The demand continues to increase as the majority of the public can now afford it due to the recent expansion through insurance coverage. For instance, Medicare is the largest market player in the U.S., which provides care for those aged 65 years and above, irrespective of their income and medical history.
Owing to the COVID-19 pandemic, the demand side showcased a positive impact on the ISH market as various researchers employed the technique on COVID-19-infected cells. Research published in July 2020, considered 8 autopsy lungs, 10 kidney biopsies, and 1 placenta from COVID-19-infected patients with ISH assay and RNA probes.
COVID-19 positive results showed in all 8 lungs and the placenta by ISH, but not in the kidney samples. The assay showcases a sensitive and specific technique for detecting the virus from tissue samples. Similarly, Advanced Cell Diagnostics, Inc., introduced RNAscope technology to support COVID-19 research.
The growing strategic initiatives by the companies are anticipated to boost the ISH market growth. Key players are introducing novel products in the market to strengthen their portfolios. For instance, in March 2021, F. Hoffmann-La Roche launched DISCOVERY Green HRP chromogen detection kit to expand the multiplexing capability of in situ hybridization and immunohistochemistry.
On the other hand, molecular diagnostics renders accurate & effective results and has indispensable applications in the field of diagnosis. However, the high manufacturing cost of FISH assays and the high amount of capital required for specialized assembly plants & maintenance of instruments used in FISH imaging are likely to limit revenue generation.
In Situ Hybridization Market Report Highlights
- By technology, the CISH segment is projected to expand at the fastest growth rate during the forecast period. Since the reagents used in CISH are more stable, the sample can be stored for a longer duration and can be examined multiple times
- By probe, the DNA segment is anticipated to have the fastest growth rate during the forecast period. Owing to the increasing incidence of diseases associated with chromosomal aberrations, such as genetic abnormalities and cancer
- By product, the services segment is anticipated to have the fastest-growing CAGR between 2024 to 2030. Increasing outsourcing to ensure high adherence to quality standards and improve operational functionalities contributes to the lucrative growth.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective - 1
1.2.2. Objective - 2
1.2.3. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective - 1
1.2.2. Objective - 2
1.2.3. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Rising Prevalence of Target Disorders
3.4.2. Technological Advancement In the Field of In Vitro Diagnostics
3.4.3. Increasing R&D Investments In In Vitro Diagnostics
3.5. Market Restraint Analysis
3.5.1. High Cost of ISH
3.5.2. Presence of An Ambiguous Regulatory Framework
3.6. Penetration and Growth Prospect Mapping 2023
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.2. Porter’s Five Forces Analysis
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Rising Prevalence of Target Disorders
3.4.2. Technological Advancement In the Field of In Vitro Diagnostics
3.4.3. Increasing R&D Investments In In Vitro Diagnostics
3.5. Market Restraint Analysis
3.5.1. High Cost of ISH
3.5.2. Presence of An Ambiguous Regulatory Framework
3.6. Penetration and Growth Prospect Mapping 2023
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.2. Porter’s Five Forces Analysis
Chapter 4. Technology Business Analysis
4.1. In Situ Hybridization Market: Product Type Movement Analysis
4.2. FISH
4.2.1. FISH Market, 2018-2030 (USD Million)
4.3. CISH
4.3.1. CISH Market, 2018-2030 (USD Million)
4.2. FISH
4.2.1. FISH Market, 2018-2030 (USD Million)
4.3. CISH
4.3.1. CISH Market, 2018-2030 (USD Million)
Chapter 5. Probe Business Analysis
5.1. In Situ Hybridization Market: Site Movement Analysis
5.2. DNA
5.2.1. DNA Market, 2018-2030 (USD Million)
5.3. RNA
5.3.1. RNA Market, 2018-2030 (USD Million)
5.2. DNA
5.2.1. DNA Market, 2018-2030 (USD Million)
5.3. RNA
5.3.1. RNA Market, 2018-2030 (USD Million)
Chapter 6. Product Business Analysis
6.1. In Situ Hybridization Market: Site Movement Analysis
6.2. Instruments
6.2.1. Instruments Market, 2018-2030 (USD Million)
6.3. Consumables & Accessories
6.3.1. Consumables & Accessories Market, 2018-2030 (USD Million)
6.4. Software
6.4.1. Software Market, 2018-2030 (USD Million)
6.5. Services
6.5.1. Services Market, 2018-2030 (USD Million)
6.2. Instruments
6.2.1. Instruments Market, 2018-2030 (USD Million)
6.3. Consumables & Accessories
6.3.1. Consumables & Accessories Market, 2018-2030 (USD Million)
6.4. Software
6.4.1. Software Market, 2018-2030 (USD Million)
6.5. Services
6.5.1. Services Market, 2018-2030 (USD Million)
Chapter 7. Application Business Analysis
7.1. In Situ Hybridization Market: Product Type Movement Analysis
7.2. Cancer
7.2.1. Cancer Market, 2018-2030 (USD Million)
7.3. Cytogenetics
7.3.1. Cytogenetics Market, 2018-2030 (USD Million)
7.4. Developmental Biology
7.4.1. Developmental Biology Market, 2018-2030 (USD Million)
7.5. Infectious Diseases
7.5.1. Infectious Diseases Market, 2018-2030 (USD Million)
7.6. Others
7.6.1. Others Market, 2018-2030 (USD Million)
7.2. Cancer
7.2.1. Cancer Market, 2018-2030 (USD Million)
7.3. Cytogenetics
7.3.1. Cytogenetics Market, 2018-2030 (USD Million)
7.4. Developmental Biology
7.4.1. Developmental Biology Market, 2018-2030 (USD Million)
7.5. Infectious Diseases
7.5.1. Infectious Diseases Market, 2018-2030 (USD Million)
7.6. Others
7.6.1. Others Market, 2018-2030 (USD Million)
Chapter 8. End-use Business Analysis
8.1. In Situ Hybridization Market: End-use Movement Analysis
8.2. Hospitals & Diagnostic Laboratories
8.2.1. Hospitals & Diagnostic Laboratories Market, 2018-2030 (USD Million)
8.3. CROs
8.3.1. CROs Market, 2018-2030 (USD Million)
8.4. Academic & Research Institutes
8.4.1. Academic & Research Institutes Market, 2018-2030 (USD Million)
8.5. Others
8.5.1. Others Market, 2018-2030 (USD Million)
8.2. Hospitals & Diagnostic Laboratories
8.2.1. Hospitals & Diagnostic Laboratories Market, 2018-2030 (USD Million)
8.3. CROs
8.3.1. CROs Market, 2018-2030 (USD Million)
8.4. Academic & Research Institutes
8.4.1. Academic & Research Institutes Market, 2018-2030 (USD Million)
8.5. Others
8.5.1. Others Market, 2018-2030 (USD Million)
Chapter 9. Regional Business Analysis
9.1. In Situ Hybridization Market Share By Region, 2023 & 2030
9.2. North America
9.2.1. SWOT Analysis
9.2.2. North America In Situ Hybridization Market, 2018-2030 (USD Million)
9.2.3. U.S.
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Scenario
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. Reimbursement Scenario
9.2.3.6. U.S. In Situ Hybridization Market, 2018-2030 (USD Million)
9.2.4. Canada
9.2.4.1. Key Country Dynamics
9.2.4.2. Target Disease Scenario
9.2.4.3. Competitive Scenario
9.2.4.4. Regulatory Framework
9.2.4.5. Reimbursement Scenario
9.2.4.6. Canada In Situ Hybridization Market, 2018-2030 (USD Million)
9.3. Europe
9.3.1. SWOT Analysis
9.3.2. Europe In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Scenario
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. Reimbursement Scenario
9.3.3.6. Germany In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.4. UK
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Scenario
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. Reimbursement Scenario
9.3.4.6. UK In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.5. France
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Scenario
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. Reimbursement Scenario
9.3.5.6. France In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.6. Italy
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Scenario
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Reimbursement Scenario
9.3.6.6. Italy In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.7. Spain
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Scenario
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Reimbursement Scenario
9.3.7.6. Spain In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.8. Denmark
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Scenario
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Reimbursement Scenario
9.3.8.6. Denmark In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.9. Sweden
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Scenario
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Reimbursement Scenario
9.3.9.6. Sweden In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.10. Norway
9.3.10.1. Key Country Dynamics
9.3.10.2. Target Disease Scenario
9.3.10.3. Competitive Scenario
9.3.10.4. Regulatory Framework
9.3.10.5. Reimbursement Scenario
9.3.10.6. Norway In Situ Hybridization Market, 2018-2030 (USD Million)
9.4. Asia-Pacific
9.4.1. SWOT Analysis
9.4.2. Asia-Pacific In Situ Hybridization Market, 2018-2030 (USD Million)
9.4.3. Japan
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Scenario
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. Reimbursement Scenario
9.4.3.6. Japan In Situ Hybridization Market, 2018-2030 (USD Million)
9.4.4. China
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Scenario
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. Reimbursement Scenario
9.4.4.6. China In Situ Hybridization Market, 2018-2030 (USD Million)
9.4.5. India
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Scenario
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. Reimbursement Scenario
9.4.5.6. India In Situ Hybridization Market, 2018-2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Scenario
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. Reimbursement Scenario
9.4.6.6. South Korea In Situ Hybridization Market, 2018-2030 (USD Million)
9.4.7. Australia
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Scenario
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Reimbursement Scenario
9.4.7.6. Australia In Situ Hybridization Market, 2018-2030 (USD Million)
9.4.8. Thailand
9.4.8.1. Key Country Dynamics
9.4.8.2. Target Disease Scenario
9.4.8.3. Competitive Scenario
9.4.8.4. Regulatory Framework
9.4.8.5. Reimbursement Scenario
9.4.8.6. Thailand In Situ Hybridization Market, 2018-2030 (USD Million)
9.5. Latin America
9.5.1. SWOT Analysis
9.5.2. Latin America In Situ Hybridization Market, 2018-2030 (USD Million)
9.5.3. Brazil
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Scenario
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Reimbursement Scenario
9.5.3.6. Brazil In Situ Hybridization Market, 2018-2030 (USD Million)
9.5.4. Mexico
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Scenario
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. Reimbursement Scenario
9.5.4.6. Mexico In Situ Hybridization Market, 2018-2030 (USD Million)
9.5.5. Argentina
9.5.5.1. Key Country Dynamics
9.5.5.2. Target Disease Scenario
9.5.5.3. Competitive Scenario
9.5.5.4. Regulatory Framework
9.5.5.5. Reimbursement Scenario
9.5.5.6. Argentina In Situ Hybridization Market, 2018-2030 (USD Million)
9.6. MEA
9.6.1. SWOT Analysis
9.6.2. MEA In Situ Hybridization Market, 2018-2030 (USD Million)
9.6.3. South Africa
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Scenario
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. Reimbursement Scenario
9.6.3.6. South Africa In Situ Hybridization Market, 2018-2030 (USD Million)
9.6.4. Saudi Arabia
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Scenario
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. Reimbursement Scenario
9.6.4.6. Saudi Arabia In Situ Hybridization Market, 2018-2030 (USD Million)
9.6.5. UAE
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Scenario
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. Reimbursement Scenario
9.6.5.6. UAE In Situ Hybridization Market, 2018-2030 (USD Million)
9.6.6. Kuwait
9.6.6.1. Key Country Dynamics
9.6.6.2. Target Disease Scenario
9.6.6.3. Competitive Scenario
9.6.6.4. Regulatory Framework
9.6.6.5. Reimbursement Scenario
9.6.6.6. Kuwait In Situ Hybridization Market, 2018-2030 (USD Million)
9.2. North America
9.2.1. SWOT Analysis
9.2.2. North America In Situ Hybridization Market, 2018-2030 (USD Million)
9.2.3. U.S.
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Scenario
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. Reimbursement Scenario
9.2.3.6. U.S. In Situ Hybridization Market, 2018-2030 (USD Million)
9.2.4. Canada
9.2.4.1. Key Country Dynamics
9.2.4.2. Target Disease Scenario
9.2.4.3. Competitive Scenario
9.2.4.4. Regulatory Framework
9.2.4.5. Reimbursement Scenario
9.2.4.6. Canada In Situ Hybridization Market, 2018-2030 (USD Million)
9.3. Europe
9.3.1. SWOT Analysis
9.3.2. Europe In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Scenario
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. Reimbursement Scenario
9.3.3.6. Germany In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.4. UK
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Scenario
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. Reimbursement Scenario
9.3.4.6. UK In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.5. France
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Scenario
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. Reimbursement Scenario
9.3.5.6. France In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.6. Italy
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Scenario
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Reimbursement Scenario
9.3.6.6. Italy In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.7. Spain
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Scenario
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Reimbursement Scenario
9.3.7.6. Spain In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.8. Denmark
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Scenario
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Reimbursement Scenario
9.3.8.6. Denmark In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.9. Sweden
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Scenario
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Reimbursement Scenario
9.3.9.6. Sweden In Situ Hybridization Market, 2018-2030 (USD Million)
9.3.10. Norway
9.3.10.1. Key Country Dynamics
9.3.10.2. Target Disease Scenario
9.3.10.3. Competitive Scenario
9.3.10.4. Regulatory Framework
9.3.10.5. Reimbursement Scenario
9.3.10.6. Norway In Situ Hybridization Market, 2018-2030 (USD Million)
9.4. Asia-Pacific
9.4.1. SWOT Analysis
9.4.2. Asia-Pacific In Situ Hybridization Market, 2018-2030 (USD Million)
9.4.3. Japan
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Scenario
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. Reimbursement Scenario
9.4.3.6. Japan In Situ Hybridization Market, 2018-2030 (USD Million)
9.4.4. China
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Scenario
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. Reimbursement Scenario
9.4.4.6. China In Situ Hybridization Market, 2018-2030 (USD Million)
9.4.5. India
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Scenario
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. Reimbursement Scenario
9.4.5.6. India In Situ Hybridization Market, 2018-2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Scenario
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. Reimbursement Scenario
9.4.6.6. South Korea In Situ Hybridization Market, 2018-2030 (USD Million)
9.4.7. Australia
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Scenario
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Reimbursement Scenario
9.4.7.6. Australia In Situ Hybridization Market, 2018-2030 (USD Million)
9.4.8. Thailand
9.4.8.1. Key Country Dynamics
9.4.8.2. Target Disease Scenario
9.4.8.3. Competitive Scenario
9.4.8.4. Regulatory Framework
9.4.8.5. Reimbursement Scenario
9.4.8.6. Thailand In Situ Hybridization Market, 2018-2030 (USD Million)
9.5. Latin America
9.5.1. SWOT Analysis
9.5.2. Latin America In Situ Hybridization Market, 2018-2030 (USD Million)
9.5.3. Brazil
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Scenario
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Reimbursement Scenario
9.5.3.6. Brazil In Situ Hybridization Market, 2018-2030 (USD Million)
9.5.4. Mexico
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Scenario
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. Reimbursement Scenario
9.5.4.6. Mexico In Situ Hybridization Market, 2018-2030 (USD Million)
9.5.5. Argentina
9.5.5.1. Key Country Dynamics
9.5.5.2. Target Disease Scenario
9.5.5.3. Competitive Scenario
9.5.5.4. Regulatory Framework
9.5.5.5. Reimbursement Scenario
9.5.5.6. Argentina In Situ Hybridization Market, 2018-2030 (USD Million)
9.6. MEA
9.6.1. SWOT Analysis
9.6.2. MEA In Situ Hybridization Market, 2018-2030 (USD Million)
9.6.3. South Africa
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Scenario
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. Reimbursement Scenario
9.6.3.6. South Africa In Situ Hybridization Market, 2018-2030 (USD Million)
9.6.4. Saudi Arabia
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Scenario
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. Reimbursement Scenario
9.6.4.6. Saudi Arabia In Situ Hybridization Market, 2018-2030 (USD Million)
9.6.5. UAE
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Scenario
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. Reimbursement Scenario
9.6.5.6. UAE In Situ Hybridization Market, 2018-2030 (USD Million)
9.6.6. Kuwait
9.6.6.1. Key Country Dynamics
9.6.6.2. Target Disease Scenario
9.6.6.3. Competitive Scenario
9.6.6.4. Regulatory Framework
9.6.6.5. Reimbursement Scenario
9.6.6.6. Kuwait In Situ Hybridization Market, 2018-2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.2.1. New Product Launch
10.2.2. Partnerships
10.2.3. Acquisition
10.2.4. Collaboration
10.2.5. Funding
10.3. Key Company Market Share Analysis, 2023
10.4. Company Heat Map Analysis
10.5. Company Profiles
10.5.1. . PerkinElmer, Inc.
10.5.1.1. Company Overview
10.5.1.2. Financial Performance
10.5.1.3. Product Benchmarking
10.5.1.4. Strategic Initiatives
10.5.2. Thermo Fisher Scientific, Inc.
10.5.2.1. Company Overview
10.5.2.2. Financial Performance
10.5.2.3. Product Benchmarking
10.5.2.4. Strategic Initiatives
10.5.3. BioView
10.5.3.1. Company Overview
10.5.3.2. Financial Performance
10.5.3.3. Product Benchmarking
10.5.3.4. Strategic Initiatives
10.5.4. Agilent Technologies, Inc.
10.5.4.1. Company Overview
10.5.4.2. Financial Performance
10.5.4.3. Product Benchmarking
10.5.4.4. Strategic Initiatives
10.5.5. Merck KGaA
10.5.5.1. Company Overview
10.5.5.2. Financial Performance
10.5.5.3. Product Benchmarking
10.5.5.4. Strategic Initiatives
10.5.6. Bio-Rad Laboratories, Inc.
10.5.6.1. Company Overview
10.5.6.2. Financial Performance
10.5.6.3. Product Benchmarking
10.5.6.4. Strategic Initiatives
10.5.7. OXFORD GENE TECHNOLOGY IP LIMITED
10.5.7.1. Financial Performance
10.5.7.2. Product Benchmarking
10.5.7.3. Strategic Initiatives
10.5.8. LEICA BIOSYSTEMS NUSSLOCH GMBH (DANAHER CORPORATION)
10.5.8.1. Company Overview
10.5.8.2. Financial Performance
10.5.8.3. Product Benchmarking
10.5.8.4. Strategic Initiatives
10.5.9. NEOGENOMICS LABORATORIES, INC.
10.5.9.1. Financial Performance
10.5.9.2. Product Benchmarking
10.5.9.3. Strategic Initiatives
10.5.10. ADVANCED CELL DIAGNOSTICS, INC.
10.5.10.1. Company Overview
10.5.10.2. Financial Performance
10.5.10.3. Product Benchmarking
10.5.10.4. Strategic Initiatives
10.2. Strategy Mapping
10.2.1. New Product Launch
10.2.2. Partnerships
10.2.3. Acquisition
10.2.4. Collaboration
10.2.5. Funding
10.3. Key Company Market Share Analysis, 2023
10.4. Company Heat Map Analysis
10.5. Company Profiles
10.5.1. . PerkinElmer, Inc.
10.5.1.1. Company Overview
10.5.1.2. Financial Performance
10.5.1.3. Product Benchmarking
10.5.1.4. Strategic Initiatives
10.5.2. Thermo Fisher Scientific, Inc.
10.5.2.1. Company Overview
10.5.2.2. Financial Performance
10.5.2.3. Product Benchmarking
10.5.2.4. Strategic Initiatives
10.5.3. BioView
10.5.3.1. Company Overview
10.5.3.2. Financial Performance
10.5.3.3. Product Benchmarking
10.5.3.4. Strategic Initiatives
10.5.4. Agilent Technologies, Inc.
10.5.4.1. Company Overview
10.5.4.2. Financial Performance
10.5.4.3. Product Benchmarking
10.5.4.4. Strategic Initiatives
10.5.5. Merck KGaA
10.5.5.1. Company Overview
10.5.5.2. Financial Performance
10.5.5.3. Product Benchmarking
10.5.5.4. Strategic Initiatives
10.5.6. Bio-Rad Laboratories, Inc.
10.5.6.1. Company Overview
10.5.6.2. Financial Performance
10.5.6.3. Product Benchmarking
10.5.6.4. Strategic Initiatives
10.5.7. OXFORD GENE TECHNOLOGY IP LIMITED
10.5.7.1. Financial Performance
10.5.7.2. Product Benchmarking
10.5.7.3. Strategic Initiatives
10.5.8. LEICA BIOSYSTEMS NUSSLOCH GMBH (DANAHER CORPORATION)
10.5.8.1. Company Overview
10.5.8.2. Financial Performance
10.5.8.3. Product Benchmarking
10.5.8.4. Strategic Initiatives
10.5.9. NEOGENOMICS LABORATORIES, INC.
10.5.9.1. Financial Performance
10.5.9.2. Product Benchmarking
10.5.9.3. Strategic Initiatives
10.5.10. ADVANCED CELL DIAGNOSTICS, INC.
10.5.10.1. Company Overview
10.5.10.2. Financial Performance
10.5.10.3. Product Benchmarking
10.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 4 Global In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 5 Global In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 6 Global In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 7 Global In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 8 Global In Situ Hybridization Market, by Region, 2018-2030 (USD Million)
Table 9 North America In Situ Hybridization Market, by Country, 2018-2030 (USD Million)
Table 10 North America In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 11 North America In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 12 North America In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 13 North America In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 14 North America In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 15 U.S. In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 16 U.S. In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 17 U.S. In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 18 U.S. In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 19 U.S. In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 20 Canada In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 21 Canada In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 22 Canada In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 23 Canada In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 24 Canada In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 25 Europe In Situ Hybridization Market, by Country, 2018-2030 (USD Million)
Table 26 Europe In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 27 Europe In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 28 Europe In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 29 Europe In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 30 Europe In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 31 Germany In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 32 Germany In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 33 Germany In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 34 Germany In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 35 Germany In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 36 UK In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 37 UK In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 38 UK In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 39 UK In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 40 UK In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 41 France In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 42 France In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 43 France In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 44 France In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 45 France In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 46 Italy In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 47 Italy In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 48 Italy In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 49 Italy In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 50 Italy In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 51 Spain In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 52 Spain In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 53 Spain In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 54 Spain In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 55 Spain In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 56 Sweden In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 57 Sweden In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 58 Sweden In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 59 Sweden In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 60 Sweden In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 61 Denmark In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 62 Denmark In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 63 Denmark In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 64 Denmark In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 65 Denmark In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 66 Norway In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 67 Norway In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 68 Norway In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 69 Norway In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 70 Norway In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 71 Asia-Pacific In Situ Hybridization Market, by Country, 2018-2030 (USD Million)
Table 72 Asia-Pacific In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 73 Asia-Pacific In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 74 Asia-Pacific In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 75 Asia-Pacific In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 76 Asia-Pacific In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 77 China In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 78 China In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 79 China In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 80 China In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 81 China In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 82 Japan In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 83 Japan In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 84 Japan In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 85 Japan In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 86 Japan In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 87 India In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 88 India In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 89 Indian Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 90 India In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 91 Indian Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 92 South Korea In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 93 South Korea In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 94 South Korean Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 95 South Korea In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 96 South Korean Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 97 Australia In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 98 Australia In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 99 Australia In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 100 Australia In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 101 Australia In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 102 Thailand In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 103 Thailand In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 104 Thailand In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 105 Thailand In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 106 Thailand In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 107 Latin America In Situ Hybridization Market, by Country, 2018-2030 (USD Million)
Table 108 Latin America In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 109 Latin America In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 110 Latin America In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 111 Latin America In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 112 Latin America In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 113 Brazil In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 114 Brazil In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 115 Brazil in Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 116 Brazil In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 117 Brazil In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 118 Mexico In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 119 Mexico In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 120 Mexico In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 121 Mexico In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 122 Mexico In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 123 Argentina In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 124 Argentina In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 125 Argentina In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 126 Argentina In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 127 Argentina In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 128 Middle East & Africa In Situ Hybridization Market, by Country, 2018-2030 (USD Million)
Table 129 Middle East & Africa In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 130 Middle East & Africa In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 131 Middle East & Africa In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 132 Middle East & Africa In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 133 Middle East & Africa In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 134 South Africa In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 135 South Africa In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 136 South Africa In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 137 South Africa In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 138 South Africa In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 139 Saudi Arabia In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 140 Saudi Arabia In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 141 Saudi Arabia In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 142 Saudi Arabia In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 143 Saudi Arabia In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 144 UAE In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 145 UAE In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 146 UAE In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 147 UAE In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 148 UAE In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 149 Kuwait In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 150 Kuwait In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 151 Kuwait In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 152 Kuwait In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 153 Kuwait In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 2 List of Abbreviations
Table 3 Global In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 4 Global In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 5 Global In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 6 Global In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 7 Global In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 8 Global In Situ Hybridization Market, by Region, 2018-2030 (USD Million)
Table 9 North America In Situ Hybridization Market, by Country, 2018-2030 (USD Million)
Table 10 North America In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 11 North America In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 12 North America In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 13 North America In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 14 North America In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 15 U.S. In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 16 U.S. In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 17 U.S. In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 18 U.S. In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 19 U.S. In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 20 Canada In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 21 Canada In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 22 Canada In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 23 Canada In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 24 Canada In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 25 Europe In Situ Hybridization Market, by Country, 2018-2030 (USD Million)
Table 26 Europe In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 27 Europe In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 28 Europe In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 29 Europe In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 30 Europe In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 31 Germany In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 32 Germany In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 33 Germany In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 34 Germany In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 35 Germany In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 36 UK In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 37 UK In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 38 UK In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 39 UK In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 40 UK In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 41 France In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 42 France In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 43 France In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 44 France In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 45 France In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 46 Italy In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 47 Italy In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 48 Italy In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 49 Italy In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 50 Italy In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 51 Spain In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 52 Spain In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 53 Spain In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 54 Spain In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 55 Spain In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 56 Sweden In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 57 Sweden In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 58 Sweden In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 59 Sweden In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 60 Sweden In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 61 Denmark In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 62 Denmark In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 63 Denmark In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 64 Denmark In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 65 Denmark In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 66 Norway In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 67 Norway In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 68 Norway In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 69 Norway In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 70 Norway In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 71 Asia-Pacific In Situ Hybridization Market, by Country, 2018-2030 (USD Million)
Table 72 Asia-Pacific In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 73 Asia-Pacific In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 74 Asia-Pacific In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 75 Asia-Pacific In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 76 Asia-Pacific In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 77 China In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 78 China In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 79 China In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 80 China In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 81 China In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 82 Japan In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 83 Japan In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 84 Japan In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 85 Japan In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 86 Japan In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 87 India In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 88 India In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 89 Indian Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 90 India In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 91 Indian Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 92 South Korea In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 93 South Korea In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 94 South Korean Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 95 South Korea In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 96 South Korean Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 97 Australia In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 98 Australia In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 99 Australia In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 100 Australia In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 101 Australia In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 102 Thailand In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 103 Thailand In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 104 Thailand In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 105 Thailand In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 106 Thailand In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 107 Latin America In Situ Hybridization Market, by Country, 2018-2030 (USD Million)
Table 108 Latin America In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 109 Latin America In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 110 Latin America In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 111 Latin America In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 112 Latin America In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 113 Brazil In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 114 Brazil In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 115 Brazil in Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 116 Brazil In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 117 Brazil In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 118 Mexico In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 119 Mexico In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 120 Mexico In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 121 Mexico In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 122 Mexico In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 123 Argentina In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 124 Argentina In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 125 Argentina In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 126 Argentina In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 127 Argentina In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 128 Middle East & Africa In Situ Hybridization Market, by Country, 2018-2030 (USD Million)
Table 129 Middle East & Africa In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 130 Middle East & Africa In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 131 Middle East & Africa In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 132 Middle East & Africa In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 133 Middle East & Africa In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 134 South Africa In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 135 South Africa In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 136 South Africa In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 137 South Africa In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 138 South Africa In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 139 Saudi Arabia In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 140 Saudi Arabia In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 141 Saudi Arabia In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 142 Saudi Arabia In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 143 Saudi Arabia In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 144 UAE In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 145 UAE In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 146 UAE In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 147 UAE In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 148 UAE In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
Table 149 Kuwait In Situ Hybridization Market, by Technology, 2018-2030 (USD Million)
Table 150 Kuwait In Situ Hybridization Market, by Probe Type, 2018-2030 (USD Million)
Table 151 Kuwait In Situ Hybridization Market, by Product, 2018-2030 (USD Million)
Table 152 Kuwait In Situ Hybridization Market, by Application, 2018-2030 (USD Million)
Table 153 Kuwait In Situ Hybridization Market, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 In situ hybridization market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation and validation
Figure 9 Commodity flow approach
Figure 10 Market snapshot (USD Million)
Figure 11 Segment snapshot (technology, probe & end-use)
Figure 12 Segment snapshot (product & application)
Figure 13 Competitive snapshot
Figure 14 Market trends & outlook
Figure 15 Estimated number of new cases from 2020 to 2040, both sexes, age [0-85+], globally.
Figure 16 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 17 Porter’s five forces analysis
Figure 18 In situ hybridization market: Technology type outlook key takeaways (USD Million)
Figure 19 In situ hybridization market: Technology type movement analysis
Figure 20 In situ hybridization market for FISH, 2018-2030 (USD Million)
Figure 21 In situ hybridization market for CISH, 2018-2030 (USD Million)
Figure 22 In situ hybridization market: Probe outlook key takeaways (USD Million)
Figure 23 In situ hybridization market: Probe movement analysis
Figure 24 In situ hybridization market for DNA, 2018-2030 (USD Million)
Figure 25 In situ hybridization market for RNA, 2018-2030 (USD Million)
Figure 26 In situ hybridization market: End-use outlook key takeaways (USD Million)
Figure 27 In situ hybridization market: End-use type movement analysis
Figure 28 In situ hybridization market for hospital & diagnostics laboratories, 2018-2030 (USD Million)
Figure 29 In situ hybridization market for CROs, 2018-2030 (USD Million)
Figure 30 In situ hybridization market for academic institutes, 2018-2030 (USD Million)
Figure 31 In situ hybridization market for other end-use, 2018-2030 (USD Million)
Figure 32 In situ hybridization market: Product outlook and key takeaways
Figure 33 In situ hybridization market: Product movement analysis
Figure 34 In situ hybridization market instruments, 2018-2030 (USD Million)
Figure 35 In situ hybridization kits and probes market, 2018-2030 (USD Million)
Figure 36 In situ hybridization software market, 2018-2030 (USD Million)
Figure 37 In situ hybridization services market, 2018-2030 (USD Million)
Figure 38 In situ hybridization market: Application outlook and key takeaways
Figure 39 In situ hybridization market: Application movement analysis
Figure 40 Cancer application for in situ hybridization market, 2018-2030 (USD Million)
Figure 41 Cytogenetics application for in situ hybridization market, 2018-2030 (USD Million)
Figure 42 Development biology application for in situ hybridization market, 2018-2030 (USD Million)
Figure 43 Infectious diseases application for in situ hybridization market, 2018-2030 (USD Million)
Figure 44 Other applications for in situ hybridization market, 2018-2030 (USD Million)
Figure 45 In situ hybridization market revenue, by region, 2022 & 2030 (USD Million)
Figure 46 Regional marketplace: Key takeaways
Figure 47 North America in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Key country dynamics
Figure 49 U.S. in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Cancer Incidence, 2018-2030
Figure 51 Competitive scenario
Figure 52 Key country dynamics
Figure 53 Canada in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Cancer incidence, 2018-2030
Figure 55 Competitive scenario
Figure 56 Europe in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Key country dynamics
Figure 58 UK in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 59 Cancer incidence, 2018-2030
Figure 60 Competitive scenario
Figure 61 Key country dynamics
Figure 62 Germany in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 63 Cancer incidence, 2018-2030
Figure 64 Competitive scenario
Figure 65 Key country dynamics
Figure 66 France in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 67 Cancer incidence, 2018-2030
Figure 68 Competitive scenario
Figure 69 Key country dynamics
Figure 70 Spain in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 71 Cancer incidence, 2018-2030
Figure 72 Competitive scenario
Figure 73 Key country dynamics
Figure 74 Italy in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 75 Cancer incidence, 2018-2030
Figure 76 Competitive scenario
Figure 77 Key country dynamics
Figure 78 Denmark in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 79 Target disease prevalence
Figure 80 Competitive scenario
Figure 81 Regulatory framework
Figure 82 Key country dynamics
Figure 83 Sweden in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 84 Five most common cancers in Sweden
Figure 85 Competitive scenario
Figure 86 Regulatory framework
Figure 87 Key country dynamics
Figure 88 Norway in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 89 Number of new cancer cases in 2020, both sexes, all ages
Figure 90 Competitive scenario
Figure 91 Rest of Europe market estimates and forecast, 2018-2030 (USD Million)
Figure 92 Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Figure 93 Key country dynamics
Figure 94 Japan in situ hybridization market estimates and forecast, 2018-2030 (USD Million)
Figure 95 Cancer incidence, 2018 to 2030
Figure 96 Competitive scenario
Figure 97 Key country dynamics
Figure 98 China in situ hybridization market estimates and forecast, 2018-2030 (USD Million)
Figure 99 Cancer incidence, 2018 to 2030
Figure 100 Competitive scenario
Figure 101 Key country dynamics
Figure 102 India in situ hybridization market estimates and forecast, 2018-2030 (USD Million)
Figure 103 Cancer incidence, 2018 to 2030
Figure 104 Competitive scenario
Figure 105 Key country dynamics
Figure 106 Australia in situ hybridization market estimates and forecast, 2018-2030 (USD Million)
Figure 107 Cancer incidence, 2018 to 2030
Figure 108 Competitive scenario
Figure 109 Key country dynamics
Figure 110 Thailand in situ hybridization market estimates and forecast, 2018-2030 (USD Million)
Figure 111 Cancer incidence, 2020 to 2030
Figure 112 Competitive scenario
Figure 113 Key country dynamics
Figure 114 South Korea in situ hybridization market estimates and forecast, 2018-2030 (USD Million)
Figure 115 Cancer incidence 2018 to 2030
Figure 116 Competitive scenario
Figure 117 Rest of Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Figure 118 Latin America in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 119 Key country dynamics
Figure 120 Brazil in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 121 Estimated number of new cancer cases in Brazil
Figure 122 Competitive scenario
Figure 123 Key country dynamics
Figure 124 Mexico in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 125 Estimated number of new cancer cases in Mexico
Figure 126 Competitive scenario
Figure 127 Key country dynamics
Figure 128 Argentina in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 129 Estimated number of new cancer cases in Argentina
Figure 130 Competitive scenario
Figure 131 Rest of LATAM market estimates and forecast, 2018-2030 (USD Million)
Figure 132 MEA in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 133 Key country dynamics
Figure 134 South Africa in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 135 Cancer prevalence-2018-2030
Figure 136 Competitive scenario
Figure 137 Key country dynamics
Figure 138 Saudi Arabia in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 139 Cancer prevalence-2018-2030
Figure 140 Competitive scenario
Figure 141 Key country dynamics
Figure 142 UAE in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 143 Cancer prevalence 2018-2030
Figure 144 Competitive scenario
Figure 145 Key country dynamics
Figure 146 Kuwait in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 147 Target disease prevalence
Figure 148 Competitive scenario
Figure 149 Key payors in Kuwait
Figure 150 Rest of MEA market estimates and forecast, 2018-2030 (USD Million)
Figure 151 Market participant categorization
Figure 152 In situ hybridization market share analysis, 2022
Figure 153 Strategic framework
Figure 154 Ansoff Matrix
Figure 155 Competition categorization
Figure 156 Company market position analysis (Diagnostics)
Figure 157 Company market position analysis
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation and validation
Figure 9 Commodity flow approach
Figure 10 Market snapshot (USD Million)
Figure 11 Segment snapshot (technology, probe & end-use)
Figure 12 Segment snapshot (product & application)
Figure 13 Competitive snapshot
Figure 14 Market trends & outlook
Figure 15 Estimated number of new cases from 2020 to 2040, both sexes, age [0-85+], globally.
Figure 16 SWOT analysis, by factor (political & legal, economic, and technological)
Figure 17 Porter’s five forces analysis
Figure 18 In situ hybridization market: Technology type outlook key takeaways (USD Million)
Figure 19 In situ hybridization market: Technology type movement analysis
Figure 20 In situ hybridization market for FISH, 2018-2030 (USD Million)
Figure 21 In situ hybridization market for CISH, 2018-2030 (USD Million)
Figure 22 In situ hybridization market: Probe outlook key takeaways (USD Million)
Figure 23 In situ hybridization market: Probe movement analysis
Figure 24 In situ hybridization market for DNA, 2018-2030 (USD Million)
Figure 25 In situ hybridization market for RNA, 2018-2030 (USD Million)
Figure 26 In situ hybridization market: End-use outlook key takeaways (USD Million)
Figure 27 In situ hybridization market: End-use type movement analysis
Figure 28 In situ hybridization market for hospital & diagnostics laboratories, 2018-2030 (USD Million)
Figure 29 In situ hybridization market for CROs, 2018-2030 (USD Million)
Figure 30 In situ hybridization market for academic institutes, 2018-2030 (USD Million)
Figure 31 In situ hybridization market for other end-use, 2018-2030 (USD Million)
Figure 32 In situ hybridization market: Product outlook and key takeaways
Figure 33 In situ hybridization market: Product movement analysis
Figure 34 In situ hybridization market instruments, 2018-2030 (USD Million)
Figure 35 In situ hybridization kits and probes market, 2018-2030 (USD Million)
Figure 36 In situ hybridization software market, 2018-2030 (USD Million)
Figure 37 In situ hybridization services market, 2018-2030 (USD Million)
Figure 38 In situ hybridization market: Application outlook and key takeaways
Figure 39 In situ hybridization market: Application movement analysis
Figure 40 Cancer application for in situ hybridization market, 2018-2030 (USD Million)
Figure 41 Cytogenetics application for in situ hybridization market, 2018-2030 (USD Million)
Figure 42 Development biology application for in situ hybridization market, 2018-2030 (USD Million)
Figure 43 Infectious diseases application for in situ hybridization market, 2018-2030 (USD Million)
Figure 44 Other applications for in situ hybridization market, 2018-2030 (USD Million)
Figure 45 In situ hybridization market revenue, by region, 2022 & 2030 (USD Million)
Figure 46 Regional marketplace: Key takeaways
Figure 47 North America in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 48 Key country dynamics
Figure 49 U.S. in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Cancer Incidence, 2018-2030
Figure 51 Competitive scenario
Figure 52 Key country dynamics
Figure 53 Canada in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Cancer incidence, 2018-2030
Figure 55 Competitive scenario
Figure 56 Europe in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Key country dynamics
Figure 58 UK in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 59 Cancer incidence, 2018-2030
Figure 60 Competitive scenario
Figure 61 Key country dynamics
Figure 62 Germany in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 63 Cancer incidence, 2018-2030
Figure 64 Competitive scenario
Figure 65 Key country dynamics
Figure 66 France in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 67 Cancer incidence, 2018-2030
Figure 68 Competitive scenario
Figure 69 Key country dynamics
Figure 70 Spain in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 71 Cancer incidence, 2018-2030
Figure 72 Competitive scenario
Figure 73 Key country dynamics
Figure 74 Italy in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 75 Cancer incidence, 2018-2030
Figure 76 Competitive scenario
Figure 77 Key country dynamics
Figure 78 Denmark in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 79 Target disease prevalence
Figure 80 Competitive scenario
Figure 81 Regulatory framework
Figure 82 Key country dynamics
Figure 83 Sweden in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 84 Five most common cancers in Sweden
Figure 85 Competitive scenario
Figure 86 Regulatory framework
Figure 87 Key country dynamics
Figure 88 Norway in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 89 Number of new cancer cases in 2020, both sexes, all ages
Figure 90 Competitive scenario
Figure 91 Rest of Europe market estimates and forecast, 2018-2030 (USD Million)
Figure 92 Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Figure 93 Key country dynamics
Figure 94 Japan in situ hybridization market estimates and forecast, 2018-2030 (USD Million)
Figure 95 Cancer incidence, 2018 to 2030
Figure 96 Competitive scenario
Figure 97 Key country dynamics
Figure 98 China in situ hybridization market estimates and forecast, 2018-2030 (USD Million)
Figure 99 Cancer incidence, 2018 to 2030
Figure 100 Competitive scenario
Figure 101 Key country dynamics
Figure 102 India in situ hybridization market estimates and forecast, 2018-2030 (USD Million)
Figure 103 Cancer incidence, 2018 to 2030
Figure 104 Competitive scenario
Figure 105 Key country dynamics
Figure 106 Australia in situ hybridization market estimates and forecast, 2018-2030 (USD Million)
Figure 107 Cancer incidence, 2018 to 2030
Figure 108 Competitive scenario
Figure 109 Key country dynamics
Figure 110 Thailand in situ hybridization market estimates and forecast, 2018-2030 (USD Million)
Figure 111 Cancer incidence, 2020 to 2030
Figure 112 Competitive scenario
Figure 113 Key country dynamics
Figure 114 South Korea in situ hybridization market estimates and forecast, 2018-2030 (USD Million)
Figure 115 Cancer incidence 2018 to 2030
Figure 116 Competitive scenario
Figure 117 Rest of Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Figure 118 Latin America in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 119 Key country dynamics
Figure 120 Brazil in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 121 Estimated number of new cancer cases in Brazil
Figure 122 Competitive scenario
Figure 123 Key country dynamics
Figure 124 Mexico in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 125 Estimated number of new cancer cases in Mexico
Figure 126 Competitive scenario
Figure 127 Key country dynamics
Figure 128 Argentina in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 129 Estimated number of new cancer cases in Argentina
Figure 130 Competitive scenario
Figure 131 Rest of LATAM market estimates and forecast, 2018-2030 (USD Million)
Figure 132 MEA in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 133 Key country dynamics
Figure 134 South Africa in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 135 Cancer prevalence-2018-2030
Figure 136 Competitive scenario
Figure 137 Key country dynamics
Figure 138 Saudi Arabia in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 139 Cancer prevalence-2018-2030
Figure 140 Competitive scenario
Figure 141 Key country dynamics
Figure 142 UAE in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 143 Cancer prevalence 2018-2030
Figure 144 Competitive scenario
Figure 145 Key country dynamics
Figure 146 Kuwait in situ hybridization market estimates and forecasts, 2018-2030 (USD Million)
Figure 147 Target disease prevalence
Figure 148 Competitive scenario
Figure 149 Key payors in Kuwait
Figure 150 Rest of MEA market estimates and forecast, 2018-2030 (USD Million)
Figure 151 Market participant categorization
Figure 152 In situ hybridization market share analysis, 2022
Figure 153 Strategic framework
Figure 154 Ansoff Matrix
Figure 155 Competition categorization
Figure 156 Company market position analysis (Diagnostics)
Figure 157 Company market position analysis
Companies Mentioned
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- BioView
- Agilent Technologies, Inc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- OXFORD GENE TECHNOLOGY IP LIMITED
- LEICA BIOSYSTEMS NUSSLOCH GMBH (DANAHER CORPORATION)
- NEOGENOMICS LABORATORIES, INC.
- ADVANCED CELL DIAGNOSTICS, INC.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | December 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.6 Billion |
| Forecasted Market Value ( USD | $ 2.55 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
